Considerations in Predicting Neuropsychological Outcomes in Children Treated for ALL

from Journal of Clinical Oncology (JCO) Podcast · host Brenda J. Spiegler

Randomization to different methotrexate and steroid treatment strategies was not related to neuropsychological outcome in children treated for B-ALL, but age and insurance status were significant predictors. Read the associated article "Neurocognitive Functioning of Children Treated for High-Risk B-Acute Lymphoblastic Leukemia (HRALL) Randomized to Capizzi (CMTX) Versus High- Dose Methotrexate (HDMTX): A Report From the Children's Oncology Group (COG)" on JCO.org.

Episode metadata supplied by the publisher feed · Published Jul 3, 2017

Embed this episode

Attribution link and audio player

NOW PLAYING

Considerations in Predicting Neuropsychological Outcomes in Children Treated for ALL

0:00 12:21

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Journal of Clinical Oncology (JCO) Podcast?

This episode is 12 minutes long.

When was this Journal of Clinical Oncology (JCO) Podcast episode published?

This episode was published on July 3, 2017.

Can I download this Journal of Clinical Oncology (JCO) Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!